New York Assembly Bill A00463

New York 2023-2024 Regular Session

• Introduced: 1/9/23
• Refer: 1/9/23
• Report Pass: 5/17/23
• Refer: 5/17/23
• Report Pass: 6/5/23
• Engrossed: 6/5/23
• Refer: 6/5/23
• Engrossed: 6/7/23
• Enrolled: 12/12/23
• Chaptered: 12/22/23
• Passed: 12/22/23

Caption

Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.